FDA Inspection 685477 — Novocol Pharmaceutical Of Canada, Inc.
The FDA completed an inspection of Novocol Pharmaceutical Of Canada, Inc. on Oct 22, 2010 in Cambridge. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 22, 2010
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Postmarket Surv. and Epidemiology
- Location
- Cambridge (Canada)